Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04582149 · ClinicalTrials.gov registry record · NA
Eye-Control Trial: Wearable Eye-Tracking Device as Means of Communication
A NA study, sponsored by Emory University.
- Completed
- Registry status
- NA
- Development phase
- 30
- Enrollment target
NCT04582149 is a NA study that has completed, run by Emory University. The registered enrollment target is 30 participants.
The verdict
NCT04582149, a NA study, has completed, sponsored by Emory University.
- COMPLETED
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the feasibility of use of a wearable communication device for critically ill patients who are admitted to the intensive care unit (ICU) and mechanically ventilated. The study will assess the safety, tolerability, and ease of use of the EyeControl device, and examine its potential monitoring capabilities.
Interventions
- DEVICE EyeControl Eye-tracking Device
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2021-05-19 |
| Est. Completion | 2023-01-23 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04582149
The ClinicalTrials.gov registry entry for NCT04582149 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Emory University, which has 1,208 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which EyeControl Eye-tracking Device is the first listed.
NCT04582149 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04582149 about?
NCT04582149 is a clinical study titled "Eye-Control Trial: Wearable Eye-Tracking Device as Means of Communication". The purpose of this study is to evaluate the feasibility of use of a wearable communication device for critically ill patients who are admitted to the intensive care unit (ICU) and mechanically ventilated. The study will assess the safety, tolerability, and ease of use of the EyeControl device, and ...
What is the current status of trial NCT04582149?
This trial is currently completed. It is a NA study. The enrollment target is 30 participants. The study started on 2021-05-19. Estimated completion is 2023-01-23.
What interventions are being tested in trial NCT04582149?
The interventions under investigation include: EyeControl Eye-tracking Device (DEVICE).
Who is sponsoring clinical trial NCT04582149?
This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.